Medifast Outperforms Peers with 5.2% Revenue Beat, e.l.f. Beauty Tops with 37.8% Growth

Medifast (NYSE:MED) reported Q4 revenues of $75.1 million, down 36.9% YoY, beating analysts' expectations by 5.2%. The company's full-year revenue and EPS guidance missed analysts' expectations. Despite this, Medifast had the highest full-year guidance raise among the group. e.l.f. Beauty (NYSE:ELF) reported Q4 revenues of $489.5 million, up 37.8% YoY, outperforming analysts' expectations by 6.4%. Share prices of personal care companies have had a rough stretch, with an average decline of 10.7% since the latest earnings results.